Topical Treatment of Recalcitrant Ulcerative Old World Leishmaniasis With WR 279,396
Status:
Terminated
Trial end date:
2010-06-24
Target enrollment:
Participant gender:
Summary
The primary objective of this protocol is to treat laboratory confirmed cutaneous
leishmaniasis with WR 279,396 in military health care beneficiaries. In this study "cutaneous
leishmaniasis" is defined as Old World Leishmaniasis if acquired in the Southwest Central
Asia/Middle East.
Phase:
Phase 2
Details
Lead Sponsor:
U.S. Army Medical Research and Development Command U.S. Army Medical Research and Materiel Command